" /> Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA - CISMeF





Preferred Label : Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA;

NCIt synonyms : Acute Promyelocytic Leukemia; AML with t(15;17)(q24.1;q21.2); Acute Promyelocytic Leukemia with PML::RARA; Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA; Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA Fusion; Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML::RARA Fusion;

NCIt related terms : Acute Promyelocytic Leukemia with t(15;17)(q22;q12); PML/RARA; Acute promyelocytic leukaemia, t(15;17)(q22;q11-12); Acute Promyelocytic Leukemia with PML-RARA; Acute promyelocytic leukaemia, PML-RAR-alpha; M3 OR Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA;

NCIt definition : An acute promyelocytic leukemia characterized by the reciprocal balanced translocation t(15;17)(q24.1;q21.2) that results in the fusion of the promyelocytic leukemia (PML) gene and retinoic acid receptor-α (RARA) gene. The t(15;17)(q24.1;q21.2) with the resulting PML-RARA fusion gene occurs in over 95% of cases of acute promyelocytic leukemia. The remainder of the cases show variant RARA gene translocations with other genes.;

Neoplastic status : Malignant;

ICD-O code : 9866/3;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.